The Food and Drug Administration’s accelerated approval program aims to speed “approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint” of overall ...

Please provide your email address to receive an email when new articles are posted on . Cancer drugs that received accelerated approval gained regular approval faster when their confirmatory trials ...